atai Life Sciences (Atai Beckley N.V.) is a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic treatments for mental health disorders. Founded in 2018, its pipeline includes VLS-01 (DMT oral film for treatment-resistant depression), EMP-01 (R-MDMA for social anxiety disorder), and novel 5-HT2A receptor agonists. The company also holds strategic investments in Beckley Psytech, Recognify Life Sciences, and COMPASS Pathways, and acquired drug delivery subsidiary IntelGenx Corp. in 2024.
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-17 | 2024-12-31 | 0000950170-25-040244 | EDGAR | 146K words |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038138 | EDGAR | 143K words |
| 2023-03-24 | 2022-12-31 | 0000950170-23-009756 | EDGAR | 146K words |
| 2022-03-30 | 2021-12-31 | 0000950170-22-005013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-277583 | EDGAR | 57K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108883 | EDGAR | 56K words |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071435 | EDGAR | 45K words |
| 2024-11-13 | 2024-09-30 | 0000950170-24-126515 | EDGAR | 53K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096296 | EDGAR | 50K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060044 | EDGAR | 44K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063730 | EDGAR | 52K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041345 | EDGAR | 48K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021271 | EDGAR | 43K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024162 | EDGAR | 63K words |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017253 | EDGAR | 60K words |
| 2022-05-16 | 2022-03-31 | 0000950170-22-009966 | EDGAR | 50K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-05 | 0001140361-25-044579 | EDGAR | 4K words |
| 2025-11-12 | 0001140361-25-041546 | EDGAR | 3K words |
| 2025-11-05 | 0001140361-25-040444 | EDGAR | 3K words |
| 2025-11-05 | 0001140361-25-040429 | EDGAR | 2K words |
| 2025-11-04 | 0001140361-25-040358 | EDGAR | 1K words |
| 2025-10-27 | 0001140361-25-039317 | EDGAR | 3K words |
| 2025-10-21 | 0001140361-25-038748 | EDGAR | 1K words |
| 2025-10-20 | 0001140361-25-038525 | EDGAR | 1K words |
| 2025-10-16 | 0001140361-25-038319 | EDGAR | 1K words |
| 2025-10-10 | 0001140361-25-037941 | EDGAR | 7K words |
99 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001840904 |
| Ticker | ATAI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | P7 |
| Website | https://www.ataibeckley.com |
| Listed | 2021-06-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ATAI (~200 tokens, structured JSON with cryptographic provenance)